Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - Engaged Thinking  
 Home
 About BioEndeavor
 Engaged Thinking
 Engaged Thinking Blog
 Engaged Innovation Case Studies
 Engaged Thinking Academy
 Resources
 Engaged Innovation Directory
 Capacity Development
Neglected Tropical Diseases 
Non-Communicable Diseases 

Drug Discovery 
Preclinical 
Clinical 
Healthcare 
 Add Organization 


Drug Discovery
PDE4NPD: PhosphoDiEsterase inhibitors for Neglected Parasitic DiseasesGo Back  
Organization URL

Organization:
PDE4NPD: PhosphoDiEsterase inhibitors for Neglected Parasitic Diseases

Year Established: 2012

Profile:
The PDE4NPD project enables public and private partners to join forces within the EU Seventh Framework program to tackle these healthcare needs. The consortium consists of VU University Amsterdam (NL), University of Glasgow (UK), University of Kent (UK), University of Antwerp (BE), The Spanish National Research Council (ES), Fundação Oswaldo Cruz (BR), Theodor Bilharz Research Institute (EG), European Screening Port (DE), IOTA Pharmaceuticals (UK) and Top Institute Pharma (NL) and combines various drug discovery approaches into one platform that is dedicated to developing drugs against parasite PDEs: a family of well-characterized enzymes.

In parallel, the consortium parasitology research groups will perform phenotypic screening on various parasite species to identify agents that will kill them. The consortium will further develop compounds demonstrating anti-parasitic activity through PDEs as the key drug target.


Target Sector:
Drug Discovery

Typology of Knowledge Network:
Public-Private Partnership (PPP)

Knowledge Type / Focus:
Data
Biological Materials
Biological Technology

Participant Type:
Academic
Non-Profit
Government
Private Sector

Objective / Knowledge Governance:
Cooperative Research


© 2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles